Afrit M - Search Results

1

Implantable port thrombosis in cancer patients: a monocentric experience.

Dridi M, Mejri N, Labidi S, Afrit M, Benna HE, Miled KB, Boussen H. Dridi M, et al. Among authors: afrit m. Cancer Biol Med. 2016 Sep;13(3):384-388. doi: 10.20892/j.issn.2095-3941.2016.0057. Cancer Biol Med. 2016. PMID: 27807505 Free PMC article.

2

Aggressive primary hepatic epithelioid hemangioendothelioma: a case report and literature review.

Afrit M, Nasri M, Labidi S, Mejri N, El Benna H, Boussen H. Afrit M, et al. Cancer Biol Med. 2017 May;14(2):187-190. doi: 10.20892/j.issn.2095-3941.2016.0105. Cancer Biol Med. 2017. PMID: 28607810 Free PMC article.

3

Inflammatory breast cancer in Tunisia from 2005 to 2010: epidemiologic and anatomoclinical transitions from published data.

Mejri N, Boussen H, Labidi S, Bouzaiene H, Afrit M, Benna F, Rahal K. Mejri N, et al. Among authors: afrit m. Asian Pac J Cancer Prev. 2015;16(3):1277-80. doi: 10.7314/apjcp.2015.16.3.1277. Asian Pac J Cancer Prev. 2015. PMID: 25735367 Free article.

4

Relapse profile of early breast cancer according to immunohistochemical subtypes: guidance for patient's follow up?

Mejri N, Boussen H, Labidi S, Benna F, Afrit M, Rahal K. Mejri N, et al. Among authors: afrit m. Ther Adv Med Oncol. 2015 May;7(3):144-52. doi: 10.1177/1758834015576141. Ther Adv Med Oncol. 2015. PMID: 26674096 Free PMC article.

5

Aromatase inhibitor-induced carpal tunnel syndrome: prevalence in daily practice.

Labidi S, Mejri N, El Benna H, Afrit M, Lakhdhar S, Boussen H. Labidi S, et al. Among authors: afrit m. Cancer Chemother Pharmacol. 2016 Dec;78(6):1311-1315. doi: 10.1007/s00280-016-3190-8. Epub 2016 Nov 5. Cancer Chemother Pharmacol. 2016. PMID: 27817058

6

Correction to: Aromatase inhibitor-induced carpal tunnel syndrome: prevalence in daily practice.

Labidi S, Mejri N, El Benna H, Afrit M, Lakhdher S, Boussen H. Labidi S, et al. Among authors: afrit m. Cancer Chemother Pharmacol. 2019 Jan;83(1):215. doi: 10.1007/s00280-018-3745-y. Cancer Chemother Pharmacol. 2019. PMID: 30535957

7

Targeted Therapies in HER2-Overexpressing Metastatic Breast Cancer.

Labidi S, Mejri N, Lagha A, Daoud N, El Benna H, Afrit M, Boussen H. Labidi S, et al. Among authors: afrit m. Breast Care (Basel). 2016 Dec;11(6):418-422. doi: 10.1159/000452194. Epub 2016 Nov 15. Breast Care (Basel). 2016. PMID: 28228709 Free PMC article. Review.

8

First site of recurrence after breast cancer adjuvant treatment in the era of multimodality therapy: which imaging for which patient during follow-up?

Mejri N, Benna M, El Benna H, Soumaya L, Afrit M, Zouari B, Boussen H. Mejri N, et al. Among authors: afrit m. Breast Dis. 2018;37(3):123-132. doi: 10.3233/BD-170290. Breast Dis. 2018. PMID: 29171964

9

[Aromatases inhibitors for breast cancer in menopausal patients].

Afrit M, Laabidi S, Meddeb K, Skhiri H, Zayane A, Boussen H. Afrit M, et al. Tunis Med. 2013 Jan;91(1):6-11. Tunis Med. 2013. PMID: 23404601 Free article. Review. French.

10

[Medical therapies for locally advanced/metastatic kidney cancer].

Afrit M, Yahyaoui Y, Bouzouita A, Hantous S, Labidi S, Chebil M, Ben Miled K, Escudier B, Boussen H. Afrit M, et al. Presse Med. 2015 Feb;44(2):135-43. doi: 10.1016/j.lpm.2014.07.020. Epub 2014 Dec 18. Presse Med. 2015. PMID: 25535168 Review. French.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

57 results

Search Page

Filters